av Kristofer | 22 maj, 2026 | Nyheter, LSI Zeta
Celebration! Happy to precent LSI Zeta second investment; Mesenkia Therapeutics AB✨ . Specializing in the development of next generation single domain antibodies. Mesenkia is a pre-clinical company developing the hashtag#next-generation biological drug candidates...
av Kristofer | 13 mars, 2026 | Nyheter, LSI Zeta
It is with great joy we can present LSI Zetas first investment CubaseBio. Drug discovery is still slow, expensive, and inefficient.While hashtag#organoids are becoming a powerful model system, researchers lack spatial tools that scale with these complex...
